These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 19539780

  • 1. Reduction of oxidative stress does not attenuate the development of angiotensin II-dependent hypertension in Ren-2 transgenic rats.
    Kopkan L, Husková Z, Vanourková Z, Thumová M, Skaroupková P, Malý J, Kramer HJ, Dvorák P, Cervenka L.
    Vascul Pharmacol; 2009; 51(2-3):175-81. PubMed ID: 19539780
    [Abstract] [Full Text] [Related]

  • 2. Effects of changes in sodium balance on plasma and kidney angiotensin II levels in anesthetized and conscious Ren-2 transgenic rats.
    Husková Z, Kramer HJ, Vanourková Z, Cervenka L.
    J Hypertens; 2006 Mar; 24(3):517-27. PubMed ID: 16467655
    [Abstract] [Full Text] [Related]

  • 3. Roles of nitric oxide and oxidative stress in the regulation of blood pressure and renal function in prehypertensive Ren-2 transgenic rats.
    Vanecková I, Kramer HJ, Novotná J, Kazdová L, Opocenský M, Bader M, Ganten D, Cervenka L.
    Kidney Blood Press Res; 2005 Mar; 28(2):117-26. PubMed ID: 15795515
    [Abstract] [Full Text] [Related]

  • 4. Superoxide and its interaction with nitric oxide modulates renal function in prehypertensive Ren-2 transgenic rats.
    Kopkan L, Husková Z, Vanourková Z, Thumová M, Skaroupková P, Cervenka L, Majid DS.
    J Hypertens; 2007 Nov; 25(11):2257-65. PubMed ID: 17921820
    [Abstract] [Full Text] [Related]

  • 5. Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic rats.
    Chábová VC, Kramer HJ, Vanecková I, Vernerová Z, Eis V, Tesar V, Skaroupková P, Thumová M, Schejbalová S, Husková Z, Vanourková Z, Kolský A, Imig JD, Cervenka L.
    Vascul Pharmacol; 2007 Nov; 47(2-3):145-59. PubMed ID: 17604232
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 rat.
    Whaley-Connell A, Govindarajan G, Habibi J, Hayden MR, Cooper SA, Wei Y, Ma L, Qazi M, Link D, Karuparthi PR, Stump C, Ferrario C, Sowers JR.
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E355-63. PubMed ID: 17440033
    [Abstract] [Full Text] [Related]

  • 7. Effects of dietary salt load and salt depletion on the course of hypertension and angiotensin II levels in male and female heterozygous Ren-2 transgenic rats.
    Husková Z, Kramer H, Vanourková Z, Thumová M, Malý J, Opocenský M, Skaroupková P, Kolský A, Vernerová Z, Cervenka L.
    Kidney Blood Press Res; 2007 Jul; 30(1):45-55. PubMed ID: 17259738
    [Abstract] [Full Text] [Related]

  • 8. Persistent antihypertensive effect of aliskiren is accompanied by reduced proteinuria and normalization of glomerular area in Ren-2 transgenic rats.
    Rakusan D, Kujal P, Kramer HJ, Husková Z, Vanourková Z, Vernerová Z, Mrázová I, Thumová M, Cervenka L, Vanecková I.
    Am J Physiol Renal Physiol; 2010 Oct; 299(4):F758-66. PubMed ID: 20668096
    [Abstract] [Full Text] [Related]

  • 9. Effects of anesthesia on plasma and kidney ANG II levels in normotensive and ANG II-dependent hypertensive rats.
    Husková Z, Kramer HJ, Thumová M, Vanourková Z, Bürgelová M, Teplan V, Malý J, Cervenka L.
    Kidney Blood Press Res; 2006 Oct; 29(2):74-83. PubMed ID: 16651849
    [Abstract] [Full Text] [Related]

  • 10. Simvastatin reverses target organ damage and oxidative stress in Angiotensin II hypertension: comparison with apocynin, tempol, and hydralazine.
    Rugale C, Delbosc S, Mimran A, Jover B.
    J Cardiovasc Pharmacol; 2007 Sep; 50(3):293-8. PubMed ID: 17878758
    [Abstract] [Full Text] [Related]

  • 11. Cardiac and renal antioxidant enzymes and effects of tempol in hyperthyroid rats.
    Moreno JM, Rodríguez Gómez I, Wangensteen R, Osuna A, Bueno P, Vargas F.
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E776-83. PubMed ID: 15941780
    [Abstract] [Full Text] [Related]

  • 12. The antioxidant tempol prevents and partially reverses dexamethasone-induced hypertension in the rat.
    Zhang Y, Croft KD, Mori TA, Schyvens CG, McKenzie KU, Whitworth JA.
    Am J Hypertens; 2004 Mar; 17(3):260-5. PubMed ID: 15001201
    [Abstract] [Full Text] [Related]

  • 13. Combined suppression of the intrarenal and circulating vasoconstrictor renin-ACE-ANG II axis and augmentation of the vasodilator ACE2-ANG 1-7-Mas axis attenuates the systemic hypertension in Ren-2 transgenic rats exposed to chronic hypoxia.
    Červenka L, Bíbová J, Husková Z, Vaňourková Z, Kramer HJ, Herget J, Jíchová Š, Sadowski J, Hampl V.
    Physiol Res; 2015 Mar; 64(1):11-24. PubMed ID: 25194129
    [Abstract] [Full Text] [Related]

  • 14. AT1 receptor antisense therapy transiently lowers blood pressure in Ren-2 transgenic rats.
    Vanecková I, Kopkan L, Husková Z, Vanourková Z, Schejbalová S, Cervenka L, Kramer HJ.
    Vascul Pharmacol; 2007 Jul; 47(1):63-7. PubMed ID: 17521968
    [Abstract] [Full Text] [Related]

  • 15. Castration has antihypertensive and organoprotective effects in male but not in female heterozygous Ren-2 rats.
    Vaněčková I, Husková Z, Vaňourková Z, Cervenka L.
    Kidney Blood Press Res; 2011 Jul; 34(1):46-52. PubMed ID: 21178362
    [Abstract] [Full Text] [Related]

  • 16. Inappropriately high circulating and intrarenal angiotensin II levels during dietary salt loading exacerbate hypertension in Cyp1a1-Ren-2 transgenic rats.
    Husková Z, Vanourková Z, Erbanová M, Thumová M, Opocenský M, Mullins JJ, Kramer HJ, Bürgelová M, Cervenka L.
    J Hypertens; 2010 Mar; 28(3):495-509. PubMed ID: 19927008
    [Abstract] [Full Text] [Related]

  • 17. Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction wtih the renin-angiotension system.
    Iglarz M, Touyz RM, Viel EC, Amiri F, Schiffrin EL.
    Am J Hypertens; 2004 Jul; 17(7):597-603. PubMed ID: 15243979
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin II formation in the kidney and nephrosclerosis in Ren-2 hypertensive rats.
    Hartner A, Porst M, Klanke B, Cordasic N, Veelken R, Hilgers KF.
    Nephrol Dial Transplant; 2006 Jul; 21(7):1778-85. PubMed ID: 16522658
    [Abstract] [Full Text] [Related]

  • 19. Endothelin receptor blockade does not affect blood pressure or angiotensin II levels in CYP1A1-Ren-2 transgenic rats with acutely induced hypertension.
    Vanourková Z, Kramer HJ, Erbanová M, Bäcker A, Cervenka L, Husková Z, Chábová VC, Tesar V, Dvorák P, Malý J, Vanecková I.
    Vascul Pharmacol; 2009 Jul; 50(5-6):194-9. PubMed ID: 19563737
    [Abstract] [Full Text] [Related]

  • 20. Effects of captopril, losartan, and nifedipine on cell hypertrophy of cultured vascular smooth muscle from hypertensive Ren-2 transgenic rats.
    Peiró C, Llergo JL, Angulo J, López-Novoa JM, Rodríguez-López A, Rodríguez-Mañas L, Sánchez-Ferrer CF.
    Br J Pharmacol; 1997 Aug; 121(7):1438-44. PubMed ID: 9257925
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.